European Healthtech startup funding raised during March 2022.
In March 2022, 46 European Healthtech companies raised a combined €916M across 46 funding rounds, up 85.4% versus March 2021. France led by capital raised, and Bpifrance was the most active investor. Data as of 9 Jul 2026.
5 exits.
| €37M |
| In Ovo | Series B | Mar 2022 | €34M |
| Scenic Biotech | Series A | Mar 2022 | €28M |
| Synapse Medicine | Series B | Mar 2022 | €25M |
| Kither Biotech | Series B | Mar 2022 | €19M |
| Lantum | Other | Mar 2022 | €14M |
| LenioBio | Series A | Mar 2022 | €12M |
| Vira Health | Other | Mar 2022 | €11M |
| Sano Genetics | Series A | Mar 2022 | €10M |
| Core Biogenesis | Other | Mar 2022 | €10M |
| Diadem | Other | Mar 2022 | €10M |
| DasLab | Other | Mar 2022 | €6.2M |
